As NAFTA negotiations continue, we urge you to sign our “NAFTA and International Public Health: An Interfaith Call for Access to Medicines” statement. We ask that any future trade policies will take into account the immense suffering of vulnerable populations caused by the lack of access to medicines. It is important that world leaders hear a unified voice from institutions and individuals across the country that access to medicines is essential. Let us join our voices together as an interfaith coalition and have signers to the letter include every state and territory of The United States of America!
Current signers include:
Most Reverend Timothy P. Broglio
Chairman of the Committee on International Justice and Peace, The United States Conference of Catholic Bishops
Most Reverend Michael B. Curry
Presiding Bishop and Primate, The Episcopal Church
Reverend Dr. Susan Henry-Crowe
General Secretary of the General Board of Church and Society, The United Methodist Church
Reverend Dr. John C. Dorhauer
General Minister and President, The United Church of Christ
Reverend Elizabeth A. Eaton
Presiding Bishop, The Evangelical Lutheran Church in America
Reverend Dr. J. Herbert Nelson
Stated Clerk of the General Assembly, The Presbyterian Church (U.S.A.)
Executive Director, Jubilee USA Network
NAFTA and International Public Health: An Interfaith Call for Access to Medicines
Recognizing the inherent dignity of the human person, our faith traditions call us to care for the sick and respond to the needs of the poor in our societies. Trade agreements can have enormous impacts on the ability of the sick and the poor to access the medicines they need for healing and even survival.
Therefore, we agree with the provisions of the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), currently in effect in all NAFTA countries. The TRIPS agreement calls for respect of intellectual property rights, including those for medicines. Crucially, as was underscored by the Doha Declaration on TRIPS and Public Health, it also recognizes each nation’s right to take necessary steps to ensure that medicines are available to all of their residents.
We would also like to take this opportunity to commend the Administration’s defense of sovereignty on the issue of investor-state arbitration; each state has not only the right but the obligation to safeguard the common good within their nations.
At this time, we recall the Bipartisan Agreement on Trade Policy espoused by President George W. Bush and leaders of both parties in Congress in May 2007. This “May 10th Agreement” recognizes the flexibility in intellectual property rights provisions with regard to pharmaceuticals that developing countries sometimes need in order to serve the public health needs of their people. We hope our political leaders can come together once again on these principles in support of the most vulnerable.
We call on you to ensure that no terms of a renegotiated NAFTA go beyond the TRIPS agreement mandates, and avoid enhanced and extended monopolies on life-essential medicines. Instead, we ask that a renegotiated NAFTA reaffirm the TRIPS public health protections that enable the United States and other countries to promote the human right to health and access to medicines for all.